Cui Jingrong Jean
SEC insider (Form 3/4/5 filer). CIK 0001772259. President and CEO at BlossomHill Therapeutics, Inc. (BLSM). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SAN DIEGO, CA.
Companies Cui Jingrong Jean has filed insider reports for
- BlossomHill Therapeutics, Inc. (BLSM): Director, Officer, 10% Owner, President and CEO
Cui Jingrong Jean
CIK: 0001772259
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BLSM
BlossomHill Therapeutics, Inc.
DirectorOfficer10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
ConversionIndirect1.6M shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
ConversionIndirect113.4K shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
ConversionIndirect124.8K shares- - Aug 6, 2026BLSM
BlossomHill Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
676.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion | 1,600,682 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion | 113,435 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion | 124,779 | - | $0 | Indirect |
| Aug 6, 2026 | BLSM BlossomHill Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 676,205 | - | - | Direct |
1-4 of 4 transactions